Herbas VPB

Spausdinti
EN | LT
LT - HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
EN - HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

Teisinis statusas

Patentas neįsigaliojo (pagal EPK)

Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
(51) INT.CL. C07D 401/14 (2006.01)
C07D 405/14 (2013.01)
C07D 401/14 (2013.01)
C07D 405/14 (2006.01)
C07D 401/12 (2013.01)
C07D 401/12 (2006.01)
A61K 31/513 (2006.01)
A61K 31/444 (2013.01)
A61K 31/506 (2013.01)
A61K 31/501 (2006.01)
A61K 31/497 (2006.01)
A61K 31/501 (2013.01)
A61P 25/00 (2006.01)
A61K 31/513 (2013.01)
A61K 31/444 (2006.01)
A61P 13/12 (2018.01)
A61K 31/506 (2006.01)
A61P 25/00 (2018.01)
A61P 25/04 (2018.01)
A61P 25/06 (2018.01)
A61P 25/14 (2018.01)
A61P 25/16 (2018.01)
A61P 25/18 (2018.01)
A61P 25/22 (2018.01)
A61P 25/24 (2018.01)
A61P 25/28 (2018.01)
A61P 25/30 (2018.01)
A61P 27/02 (2018.01)
A61P 3/04 (2018.01)
A61P 3/12 (2018.01)
A61P 31/04 (2018.01)
A61P 3/06 (2018.01)
A61P 37/02 (2018.01)
A61P 7/00 (2018.01)
A61P 7/12 (2018.01)
A61P 9/04 (2018.01)
A61P 9/10 (2018.01)
A61P 9/12 (2018.01)
A61P 3/10 (2018.01)
Europos patentas
(11) Patento numeris 3421462
(13) Dokumento rūšis T
(96) Europos patento paraiškos numeris 18180416.2
Europos patento paraiškos padavimo data 2014-06-13
(97) Europos patento paraiškos paskelbimo data 2019-01-02
(45) Paskelbimo apie Europos patento išdavimą data 2023-04-05
(46) Apibrėžties vertimo paskelbimo data
Prioriteto paraiškos
(30) Numeris Data Šalis
201361840144 P 2013-06-27 US
Išradėjai
(72)
BRODNEY, Michael Aaron , US
DAVOREN, Jennifer Elizabeth , US
DOUNAY, Amy Beth , US
EFREMOV, Ivan Viktorovich , US
GRAY, David Lawrence Firman , US
GREEN, Michael Eric , US
HENDERSON, Jaclyn Louise , US
LEE, Chewah , US
MENTE, Scot Richard , US
O'NEIL, Steven Victor , US
ROGERS, Bruce Nelsen , US
ZHANG, Lei , US
Savininkas
(73) Pfizer Inc. , 66 Hudson Boulevard East, New York, NY 10001-2192, US
Pavadinimas
(54) HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
  HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS